Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
about
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine.Deep learning in pharmacogenomics: from gene regulation to patient stratification.Value of Supportive Care Pharmacogenomics in Oncology Practice.The Patient in Precision Medicine: A Systematic Review Examining Evaluations of Patient-Facing Materials
P2860
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@ast
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@en
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@nl
type
label
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@ast
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@en
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@nl
prefLabel
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@ast
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@en
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@nl
P2860
P3181
P356
P1476
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
@en
P2093
Jai N Patel
P2860
P3181
P356
10.2147/PGPM.S62918
P407
P577
2016-01-01T00:00:00Z